RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BLASI F
Collezione AO Ordine Mauriziano

Items : 8

Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI). in The World Allergy Organization journal / World Allergy Organ J. 2024 Dec 27;18(1):101016. doi: 10.1016/j.waojou.2024.101016. eCollection 2025

2025
AO Ordine Mauriziano

Canonica GW; Blasi F; Paggiaro P; Heffler E; Braido F; Brussino L; Scioscia G; Cardini C; Oriecuia C; Sala I; Bagnardi V;

Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort. in The World Allergy Organization journal / World Allergy Organ J. 2024 Jul 29;17(8):100941. doi: 10.1016/j.waojou.2024.100941. eCollection 2024

2024
AO Ordine Mauriziano

Caminati M; Marcon A; Vaia R; Senna G; Maule M; Marchetti P; Miotti J; Argentino G; Blasi F; Canonica GW; Heffler EM; Paggiaro P; Vianello A; Guarnieri G;

Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders. in Biomedicines / Biomedicines. 2023 Aug 30;11(9):2424. doi: 10.3390/biomedicines11092424.

2023
AO Ordine Mauriziano

Bagnasco D; Nicola S; Testino E; Brussino L; Pini L; Caminati M; Piccardo F; Canevari RF; Melissari L; Ioppi A; Guastini L; Lombardi C; Milanese M; Losa F; Robbiano M; De Ferrari L; Riccio AM; Guida G; Bonavia M; Fini D; Balbi F; Caruso C; Paggiaro P; Blasi F; Heffler E; Paoletti G; Canonica GW; Senna G; Passalacqua G; et alii...

Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center. in Biomedicines / Biomedicines. 2022 Jan 18;10(2):200. doi: 10.3390/biomedicines10020200.

2022
AO Ordine Mauriziano

Solidoro P; Nicola S; Ridolfi I; Canonica GW; Blasi F; Paggiaro P; Heffler E; Bagnasco D; Patrucco F; Ribolla F; Bucca C; Rolla G; Albera C; Brussino L;

COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments. in Allergy / Allergy. 2021 Mar;76(3):887-892. doi: 10.1111/all.14532. Epub 2020 Aug 20.

2021
AO Ordine Mauriziano

Paggiaro P; Senna G; Gerli AG; Centanni S; Guida G; Padovani M; Morrone D; Crimi C; Brussino L; Malipiero G; Paoletti G; Papi A; Contoli M; Detoraki A; Heffler E; Blasi F; Canonica GW;

Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? in Allergy / Allergy. 2021 Mar;76(3):961-962. doi: 10.1111/all.14593.

2021
AO Ordine Mauriziano

Paggiaro P; Senna G; Gerli AG; Centanni S; Guida G; Padovani M; Morrone D; Crimi C; Brussino L; Malipiero G; Paoletti G; Papi A; Contoli M; Detoraki A; Heffler E; Blasi F; Canonica GW;

Aspergillus-related diseases in a cohort of patients with severe asthma: A SANI single-center report. in The journal of allergy and clinical immunology. In practice / J Allergy Clin Immunol Pract. 2021 Jul;9(7):2920-2922.e2. doi: 10.1016/j.jaip.2021.04.011. Epub 2021

2021
AO Ordine Mauriziano

Rolla G; Paggiaro P; Blasi F; Canonica GW; Bagnasco D; Bucca C; Heffler E; Ridolfi I; Nicola S; Solidoro P; Brussino L;

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry. in Journal of asthma and allergy / J Asthma Allergy. 2020 Nov 10;13:599-604. doi: 10.2147/JAA.S274245. eCollection 2020.

2020
AO Ordine Mauriziano

Puggioni F; Brussino L; Canonica GW; Blasi F; Paggiaro P; Caminati M; Latorre M; Heffler E; Senna G;